MeSH term
Frequency | Condition_Probility | Adenosinetriphosphatase/genetics/metabolism | 2 | 8.0 |
Animals | 43 | 0.0 |
*DNA Repair Enzymes | 56 | 58.0 |
DNA-Binding Proteins/genetics/metabolism | 4 | 0.0 |
Exons | 3 | 0.0 |
Female | 38 | 0.0 |
Male | 37 | 0.0 |
Mice | 39 | 0.0 |
Mice, Inbred C57BL | 10 | 0.0 |
Mice, Mutant Strains | 5 | 0.0 |
Microsatellite Repeats | 11 | 0.0 |
Molecular Sequence Data | 23 | 0.0 |
Neoplasm Proteins/genetics/metabolism | 2 | 1.0 |
Research Support, Non-U.S. Gov't | 56 | 0.0 |
DNA Damage | 4 | 0.0 |
*DNA Repair | 17 | 2.0 |
Humans | 74 | 0.0 |
Models, Biological | 2 | 0.0 |
Neoplasms/*genetics | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 42 | 0.0 |
Adult | 21 | 0.0 |
Base Pair Mismatch | 16 | 9.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics | 12 | 12.0 |
DNA Repair/physiology | 2 | 5.0 |
DNA-Binding Proteins/*genetics/physiology | 2 | 2.0 |
Middle Aged | 25 | 0.0 |
Adenine Phosphoribosyltransferase/*genetics | 2 | 8.0 |
*Base Pair Mismatch | 23 | 25.0 |
Base Sequence | 21 | 0.0 |
Mice, Knockout | 11 | 0.0 |
*Point Mutation | 2 | 0.0 |
Adenocarcinoma/pathology | 2 | 2.0 |
*DNA-Binding Proteins | 34 | 1.0 |
*Drug Resistance, Neoplasm | 4 | 2.0 |
Neoplasm Proteins/biosynthesis/*genetics | 2 | 2.0 |
Proto-Oncogene Proteins/biosynthesis/*genetics | 2 | 3.0 |
Tumor Cells, Cultured | 9 | 0.0 |
DNA Mutational Analysis | 8 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Germ-Line Mutation/*genetics | 5 | 3.0 |
Neoplasm Proteins/*genetics | 8 | 0.0 |
Pedigree | 10 | 0.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Proto-Oncogene Proteins/*genetics | 5 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Cell Line | 6 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Hydrolysis | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Proteins/metabolism | 2 | 0.0 |
Time Factors | 6 | 0.0 |
Adenosinetriphosphatase/*physiology | 2 | 33.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
Loss of Heterozygosity | 4 | 0.0 |
*Mutation | 11 | 0.0 |
Neoplasm Proteins/*physiology | 2 | 2.0 |
Ultraviolet Rays | 2 | 0.0 |
DNA/genetics | 5 | 0.0 |
*Immunoglobulin Class Switching | 2 | 15.0 |
Recombination, Genetic | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Crosses, Genetic | 5 | 0.0 |
Mutation | 9 | 0.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics/*metabolism | 2 | 66.0 |
Base Pair Mismatch/genetics | 6 | 13.0 |
DNA Repair/genetics | 9 | 5.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Mutation/*genetics | 4 | 0.0 |
Neoplasm Proteins/*genetics/metabolism | 2 | 1.0 |
Hela Cells | 5 | 0.0 |
Proto-Oncogene Proteins/deficiency/genetics | 2 | 40.0 |
Child | 6 | 0.0 |
DNA-Binding Proteins/*genetics | 4 | 0.0 |
Syndrome | 3 | 0.0 |
Adolescent | 5 | 0.0 |
DNA Methylation | 3 | 0.0 |
Immunohistochemistry | 10 | 0.0 |
*Microsatellite Repeats | 3 | 1.0 |
Neoplasm Proteins/genetics | 9 | 1.0 |
Blotting, Western | 4 | 0.0 |
Disease Progression | 3 | 0.0 |
Microsatellite Repeats/genetics | 7 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
*Adenosinetriphosphatase | 29 | 39.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/genetics | 3 | 6.0 |
Comparative Study | 10 | 0.0 |
DNA Repair/*genetics | 20 | 6.0 |
Gene Expression | 5 | 0.0 |
Neoplasm Proteins/biosynthesis/genetics | 3 | 2.0 |
Proto-Oncogene Proteins/biosynthesis/genetics | 3 | 3.0 |
Age of Onset | 2 | 0.0 |
Base Pair Mismatch/*genetics | 11 | 20.0 |
Colonic Neoplasms/genetics | 2 | 3.0 |
English Abstract | 3 | 0.0 |
Rectal Neoplasms/genetics | 2 | 22.0 |
Aged | 16 | 0.0 |
Aged, 80 and over | 7 | 0.0 |
Aging/*genetics | 2 | 3.0 |
Mice, Transgenic | 9 | 0.0 |
Alleles | 5 | 0.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
Genetic Screening | 5 | 0.0 |
Proto-Oncogene Proteins/genetics | 5 | 0.0 |
United States | 2 | 0.0 |
Mice, Inbred BALB C | 4 | 0.0 |
Neoplasm Proteins/genetics/*metabolism | 2 | 1.0 |
Prognosis | 3 | 0.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 2 | 0.0 |
Adenomatous Polyposis Coli Protein | 2 | 2.0 |
*DNA Damage | 2 | 0.0 |
Protein Biosynthesis | 4 | 0.0 |
DNA Repair/*physiology | 2 | 1.0 |
Hamsters | 3 | 0.0 |
Proteins/genetics | 3 | 0.0 |
Proto-Oncogene Proteins/genetics/metabolism | 2 | 1.0 |
*Saccharomyces cerevisiae Proteins | 3 | 0.0 |
Genetic Screening/*methods | 2 | 1.0 |
Mutation/genetics | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Genetic Predisposition to Disease | 4 | 0.0 |
Heterozygote | 3 | 0.0 |
BRCA2 Protein | 2 | 0.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Germ-Line Mutation | 3 | 0.0 |
*Germ-Line Mutation | 4 | 0.0 |
DNA Repair | 14 | 2.0 |
Genes, Reporter | 3 | 0.0 |
Genotype | 7 | 0.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
Cisplatin/pharmacology | 2 | 1.0 |
Models, Genetic | 2 | 0.0 |
Transfection | 3 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Adenoma/*genetics | 2 | 2.0 |
Colorectal Neoplasms/*genetics | 2 | 0.0 |
Proteins/*genetics/physiology | 2 | 2.0 |
Sequence Deletion | 4 | 0.0 |
Genes, APC | 2 | 2.0 |
*Multidrug Resistance-Associated Proteins | 2 | 3.0 |
Pseudogenes/*genetics | 2 | 2.0 |
Antineoplastic Agents/*pharmacology | 4 | 0.0 |
Cisplatin/*pharmacology | 3 | 2.0 |
Organoplatinum Compounds/*pharmacology | 2 | 12.0 |
Mice, Inbred Strains | 2 | 0.0 |
Microsatellite Repeats/*genetics | 4 | 1.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Species Specificity | 2 | 0.0 |
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis/genetics | 2 | 100.0 |
Genetic Techniques | 2 | 2.0 |
Phenotype | 9 | 0.0 |
Risk Factors | 2 | 0.0 |
*Genetic Screening | 2 | 1.0 |
Ploidies | 2 | 0.0 |
Neoplasm Proteins/metabolism | 3 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
*Carrier Proteins | 3 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Adenosinetriphosphatase/*genetics | 2 | 2.0 |
DNA Primers | 5 | 0.0 |
Fibroblasts | 2 | 0.0 |
Immunoglobulin Class Switching/*genetics | 2 | 20.0 |
Proteins/*genetics | 8 | 0.0 |
Mice, Knockout/*genetics | 2 | 22.0 |
DNA-Binding Proteins/analysis | 2 | 2.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Germ-Line Mutation/genetics | 3 | 4.0 |
Diagnosis, Differential | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Fungal Proteins/*genetics | 2 | 1.0 |
Organ Specificity | 2 | 0.0 |
Mutagenesis, Insertional | 2 | 0.0 |
DNA, Neoplasm | 2 | 1.0 |
Homozygote | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Family Health | 2 | 0.0 |
DNA/genetics/metabolism | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Drug Resistance, Neoplasm | 3 | 0.0 |
Adenosinetriphosphatase/*genetics/metabolism | 2 | 7.0 |
*Apoptosis | 2 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Dimerization | 2 | 0.0 |
Meiosis/*genetics | 2 | 5.0 |
Apoptosis/drug effects | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
